Frontline bortezomib, rituximab, cyclophosphamide, ...The Lancet
www.thelancet.com
... Viacheslav Pavlov, Vijay Rao Phooshkooru, Vladimir Lima, Vladimir Merkulov, Weerasak Nawarawong, Xiaonan Hong, Xiaoyan Ke, Yasuhito Terui, Yeow Tee Goh, ...
a phase III study of lenalidomide plus rituximab UGent Bibliougent.be
biblio.ugent.be
von JP Leonard · · Zitiert von: 292 — Leonard, John P, Marek Trneny, Koji Izutsu, Nathan H Fowler, Xiaonan Hong, Jun Zhu, Huilai Zhang, Fritz Offner, Adriana Scheliga, Grzegorz S ...
Bortezomib plus rituximab versus rituximab alone in patients with...
biblio.ugent.be
Bertrand Coiffier, Evgenii A Osmanov, XiaoNan Hong, Adriana Scheliga, Jiri Mayer, Fritz Offner UGent, Simon Rule, Adriana Teixeira, Jan ...
A PHASE III STUDY OF OFATUMUMAB VS RITUXIMAB IN ...library.ehaweb.org › eha › david.maloney.a.phase.ii...
library.ehaweb.org
Xiaonan Hong. ,. Xiaonan Hong. Affiliations: Cancer Hospital Affiliated to Fudan University,Shanghai,China. Michael Fennessy. ,. Michael Fennessy.
a phase III randomized study of lenalidomide plus rituximab (R-2)biblio.ugent.be › publication
biblio.ugent.be
· Leonard, John P, Marek Trneny, Koji Izutsu, Nathan H Fowler, Xiaonan Hong, Jun Zhu, Huilai Zhang, et al “AUGMENT : a Phase III ...
Bortezomib plus rituximab versus rituximab alone in patients with...
www.proquest.com
Bertrand Coiffier, Evgenii A Osmanov, Xiaonan Hong, Adriana Scheliga, Jiri Mayer, Fritz Offner, Simon Rule, Adriana Teixeira, Jan Walewski,.
Rituximab in combination with CHOP chemotherapy for the treatment of...
www.proquest.com
Xiaonan Hong & Jianmin Wang & Fangyuan Chen &. Chun Wang & Shanhua Zou & Junmin Li & Zhixiang Shen. Received: 29 October
A phase 3 study of rituximab biosimilar HLX01 in patients with ...BioMed Central
jhoonline.biomedcentral.com
von Y Shi · · Zitiert von: 22 — Xiaonan Hong. Daping Hospital, Third Affiliated Hospital of the Army Medical University, Chongqing, China. Dong Wang.
[Efficacy and safety of rituximab combined with CHOP or combined with...
www.pubfacts.com
PubFacts seeks to make the world's scientific research easy to locate, access, and collaborate on.
A phase 3 study of rituximab biosimilar HLX01 in patients with ...link.springer.com › ...
link.springer.com
Xiaonan Hong. Daping Hospital, Third Affiliated Hospital of the Army Medical University, Chongqing, China. Dong Wang. The First Bethune ...
Alle Infos zum Namen "Xiaonan Hong"
A Phase III Study of Lenalidomide Plus Rituximab Versus ...ASCO Journals
ascopubs.org
von JP Leonard · · Zitiert von: 292 — Xiaonan Hong , MD Collection and assembly of data: John P. Leonard, Marek Trneny, Koji Izutsu, Nathan H. Fowler, Xiaonan Hong, Jun Zhu, ...
A Phase III study of lenalidomide plus rituximab versus ...elsevierpure.com
mayoclinic.elsevierpure.com
von JP Leonard · · Zitiert von: 292 — John P. Leonard, Marek Trneny, Koji Izutsu, Nathan H. Fowler, Xiaonan Hong, Jun Zhu, Huilai Zhang, Fritz Offner, Adriana Scheliga, Grzegorz S. Nowakowski, ...
Bortezomib plus rituximab versus ...muni.cz
www.muni.cz
von B Coiffier · · Zitiert von: 114 — OSMANOV, Xiaonan HONG, Adriana SCHELIGA, Jiří MAYER, Fritz OFFNER, Simon RULE, Adriana TEIXEIRA, Jan WALEWSKI, Sven DE VOS, Michael CRUMP, Ofer SHPILBERG, Dixie ...
Ibrutinib plus Bendamustine and Rituximab in Untreated ...lu.se
portal.research.lu.se
von ML Wang · · Zitiert von: 49 — ... Olivier Hermine, José Ángel Hernández-Rivas, Xiaonan Hong, Seok Jin Kim, David Lewis, Yuko Mishima, Muhit Özcan, Guilherme F. Perini, ...
Ofatumumab Versus Rituximab Salvage ...Europe PMC
europepmc.org
von GW van Imhoff · · Zitiert von: 191 — ... Sungkyunkwan University School of Medicine, Seoul, Korea; Xiaonan Hong, Fudan University, Shanghai, China; Jette Soenderskov Goerloev, Rigshospitalet; ...
Ofatumumab Versus Rituximab Salvage ...rug.nl
research.rug.nl
von GW van Imhoff · · Zitiert von: 192 — ... WonSeog Kim, Xiaonan Hong, Jette Soenderskov Goerloev, Andrew Davies, Maria Dolores Caballero Barrigon, Michinori Ogura, Sirpa Leppa, ...
Randomized phase III trial of ibrutinib and rituximab plus ...University of Southampton
eprints.soton.ac.uk
von A Younes · · Zitiert von: 384 — Anas Younes · Laurie H Sehn · Peter Johnson · ORCID iD · Pier Luigi Zinzani · Xiaonan Hong · Jun Zhu · Caterina Patti · David Belada.
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or...
www.research.manchester.ac.uk
... {Kirit M} and Kazimierz Kuliczkowski and WonSeog Kim and Xiaonan Hong and Goerloev, {Jette Soenderskov} and Andrew Davies and Barrig{\'o}n, {Mar{\'i}a ...
Ofatumumab Versus Rituximab Salvage ...researchportal.helsinki.fi › publicat...
researchportal.helsinki.fi
... John Radford, Kirit M. Ardeshna, Kazimierz Kuliczkowski, WonSeog Kim, Xiaonan Hong, Jette Soenderskov Goerloev, Andrew Davies, Maria ...
Rituximab in combination with CHOP chemotherapy for the treatment of...
www.infona.pl
more. COLLAPSE. Xiaoyang Li, Zhao Liu, Junning Cao, Xiaonan Hong, Jianmin Wang, Fangyuan Chen, Chun Wang, Shanhua Zou, Junmin Li, Zhixiang Shen.
Verwandte Suchanfragen zu Xiaonan Hong
| Adriana Scheliga Dong Wang |
Person "Hong" (2) Vorname "Xiaonan" (18) Name "Hong" (3443) |
sortiert nach Relevanz / Datum